Projects per year
Personal profile
Biography
Dr Bosco completed his Bachelor of Medicine and Bachelor of Surgery with Honours in 2002 at the University of New South Wales. From 2007 - 2011 he trained in Clinical Immunology/Allergy and Immunopathology in New South Wales and Victoria, at the Westmead and Royal Melbourne Hospitals.
Since being awarded his Fellowship with the Royal Australasian College of Physicians and Royal College of Pathologists of Australasia in 2011, Dr Bosco has held Clinical Immunology and Allergy consultant positions at both the Royal Victorian Eye and Ear and the Alfred Hospitals. He also works as a consultant Immunologist and Allergist with Epworth Allergy Specialists and as an Immunopathologist with Alfred Pathology. He completed his PhD on the immunoregulatory properties of CD52 at the Walter Eliza Hall Institute of Medical Research.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Autoantibody-associated autoimmune disease
- Allergic disease
- Immunodeficiency
Collaborations and top research areas from the last five years
-
PROPHECY: Profiling immune RespOnses in Paediatric and High risk populations to SARS-CoV-2
McMahon, J. (Primary Chief Investigator (PCI)), van Zelm, M. (Chief Investigator (CI)), Khoury, G. (Chief Investigator (CI)), Drummer, H. (Chief Investigator (CI)), Mulley, W. (Chief Investigator (CI)), Holland, A. (Chief Investigator (CI)), Woolley, I. (Chief Investigator (CI)), Ojaimi, S. (Chief Investigator (CI)), Rogers, B. (Chief Investigator (CI)), Hoi, A. (Chief Investigator (CI)), Trauer, J. (Chief Investigator (CI)), Sparrow, M. (Chief Investigator (CI)), Licciardi, P. V. (Chief Investigator (CI)), Giles, E. (Chief Investigator (CI)), Curtis, D. (Chief Investigator (CI)), Crawford, N. (Associate Investigator (AI)), Leech, M. (Associate Investigator (AI)), Westall, G. (Associate Investigator (AI)), O'Hehir, R. (Associate Investigator (AI)), Jones, A. (Associate Investigator (AI)), Morand, E. (Associate Investigator (AI)), Bosco, J. J. (Associate Investigator (AI)) & Turner, S. (Associate Investigator (AI))
Monash University, Alfred Health, Monash Health, Murdoch Children's Research Institute, Burnet Institute (Australia), Spleen Australia, National Association of People with HIV Australia (NAPWHA) Incorporated, Musculoskeletal Australia , Safer Care Victoria (SCV)
1/06/22 → 30/05/26
Project: Research
-
Establishing a Jeffrey Modell Center in Melbourne, Australia.
van Zelm, M. (Primary Chief Investigator (PCI)), Choo, S. (Chief Investigator (CI)), Bosco, J. J. (Chief Investigator (CI)), Slade, C. (Chief Investigator (CI)), Bryant, V. (Chief Investigator (CI)), Ojaimi, S. (Chief Investigator (CI)), Barnes, S. (Chief Investigator (CI)), Holdsworth, S. (Chief Investigator (CI)), Gowdie, P. (Chief Investigator (CI)), Douglass, J. A. (Chief Investigator (CI)), Unglik, G. (Chief Investigator (CI)), Richards, S. (Chief Investigator (CI)), Smart, J. M. (Chief Investigator (CI)), Mehr, S. (Chief Investigator (CI)), Akikusa, J. D. (Chief Investigator (CI)), Allen, R. (Chief Investigator (CI)), Cole, T. S. (Chief Investigator (CI)), Taranto, M. (Chief Investigator (CI)), Stirling, R. (Chief Investigator (CI)), Cameron, P. U. (Chief Investigator (CI)), O'Hehir, R. (Chief Investigator (CI)), Gugasyan, R. (Chief Investigator (CI)), Masters, S. L. (Chief Investigator (CI)) & Moghaddas, F. (Chief Investigator (CI))
19/10/17 → 30/06/26
Project: Research
-
Development and standardization of assays for the functional validation of genetic variants in inborn errors of immunity
Edwards, E. (Primary Chief Investigator (PCI)), Bosco, J. J. (Associate Investigator (AI)), Ojaimi, S. (Associate Investigator (AI)), Fok, J. (Associate Investigator (AI)), Wong, N. (Associate Investigator (AI)), van Zelm, M. (Associate Investigator (AI)) & Hambleton, S. (Associate Investigator (AI))
17/04/23 → 16/04/25
Project: Research
-
Quantification of antibody levels to SARS-CoV-2 in immunoglobulin replacement therapy products, and their capacity to augment immunity in immunodeficient patients.
Edwards, E. (Primary Chief Investigator (PCI)), van Zelm, M. (Chief Investigator (CI)), Ojaimi, S. (Chief Investigator (CI)), Bosco, J. J. (Chief Investigator (CI)), O'Hehir, R. (Associate Investigator (AI)), Drummer, H. (Associate Investigator (AI)), Hogarth, M. (Associate Investigator (AI)), Daly, J. (Associate Investigator (AI)) & Murphy, J. (Associate Investigator (AI))
Allergy and Immunology Foundation of Australasia
1/10/22 → 30/11/25
Project: Research
-
Long term immune function and complication rates after splenic artery emboli zation for blunt abdominal trauma
Clements, W. (Primary Chief Investigator (PCI)), Lukies, M. W. (Associate Investigator (AI)), Kavnoudias, H. (Associate Investigator (AI)), Joseph, T. I. (Associate Investigator (AI)) & Bosco, J. J. (Associate Investigator (AI))
1/07/19 → 31/12/20
Project: Research
-
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1
Shipley, J., Beharry, J., Yeh, W., Seery, N., Foong, Y. C., Ayton, D., Siriratnam, P., Tan, T., Beadnall, H., Barton, J., Bridge, F., Wesselingh, R., Taylor, L., Rath, L., Haartsen, J., Gadi, M., Nesbitt, C., Zhong, M., Cushing, V. & McKay, F. & 31 others, , Apr 2025, In: The Medical Journal of Australia. 222, 7, p. 356-364 9 p.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus) -
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2
Shipley, J., Beharry, J., Yeh, W., Seery, N., Foong, Y. C., Ayton, D., Siriratnam, P., Tan, T., Beadnall, H., Barton, J., Bridge, F., Wesselingh, R., Taylor, L., Rath, L., Haartsen, J., Gadi, M., Nesbitt, C., Zhong, M., Cushing, V. & McKay, F. & 31 others, , Apr 2025, In: The Medical Journal of Australia. 222, 7, p. 365-371 7 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Indications and Diagnostic Yield of Paraneoplastic and Autoimmune Encephalitis Antibody Testing: A Retrospective Cohort Study
Ford, H., Seery, N., Tan, T., Gardner, L., Box, J., Wesselingh, R., Bosco, J. & Monif, M., Aug 2025, In: Brain and Behavior. 15, 8, 13 p., e70779.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Dupilumab-associated hypereosinophilia in severe asthma
Strong, A., Lin, T., Sverrild, A., Mackay, A., Lee, J., Zubrinich, C., Pham, J., Bosco, J., Denton, E., Dols, M., Stirling, R. G., Dabscheck, E., Iyer, J., Gillman, A. & Hew, M., 1 Jul 2024, In: ERJ Open Research. 10, 4, 4 p., 00048-2024.Research output: Contribution to journal › Letter › Other › peer-review
Open Access1 Citation (Scopus) -
Neutropaenia complications from Ocrelizumab and Rituximab treatment
Pang, V., Seery, N., Wesselingh, R., Yeh, W., Zhong, M., Tan, T., Dwyer, C., Nesbitt, C., Rath, L., Perera, D., Bridge, F., Skibina, O., Bosco, J. J., Jokubaitis, V., Marriott, M., Butkueven, H., Van Der Walt, A., Massey, J., Sutton, I. & Monif, M., Jan 2024, In: Multiple Sclerosis and Related Disorders. 81, 6 p., 105147.Research output: Contribution to journal › Article › Research › peer-review
Open Access11 Citations (Scopus)